UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000020837
Receipt No. R000024054
Scientific Title Effect of Additional pertuzumab for the post treatment in Patients with HER2 positive locally advanced/ metastatic Breast Cancer Who Were Previously Treated with pertuzumab - Phase II study -
Date of disclosure of the study information 2016/02/02
Last modified on 2019/01/22 19:07:38

No. Disposal Last modified on Item of update
1 Insert 2016/02/01 22:13:32
2 Update 2016/04/29 16:37:46 Email
Name of primary sponsor
Organization
3 Update 2016/04/29 17:01:38 Acronym
Acronym
4 Update 2016/04/29 21:27:41 Interventions/Control_1
Interventions/Control_1
5 Update 2018/09/23 11:59:11 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
6 Update 2019/01/22 19:07:38 Recruitment status


Contact us.